In Silico Bioequivalence – Non-Proportional Formulation
In Silico trial to replace Bioequivalence trial for non-proportional formulation
In Silico trial to replace Bioequivalence trial for non-proportional formulation
Designing and searching effective drug molecules for various diseases
Calculate acidity and basicity of small drug molecules
In silico Quantitative Structure-Toxicity Relationship (QSTR) Model for Predicting Toxicity of Aromatic Aldehydes using Extended Topochemical Atom (ETA) Indices.
Coupled computational and structure-guided approaches for Identifying Inhibitors of Escherichia coli target (AcrA and AcrB fusion proteins).
Coupled computational and structure-guided approaches for identifying NCEs inhibitors.
In silico SD Bioequivalence trial to replace clinical trial
Design from Scratch an Influenza Vaccine
In Silico trial to replace Bioequivalence trial for non-proportional formulation
In Silico trial to establish a IVIVR model based on Bioequivalence outcome